Marks defends push toward COVID vaccine boosters
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/Policy